Atlas Trials

The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D

Clinical trial NCT03246451 · COMPLETED

Trial details

NCT number
NCT03246451
Sponsor
University Hospital, Gentofte, Copenhagen
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Glucose Metabolism Disorders
Start date
2017-07-01
Primary completion
2017-12-10
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.